Walleye Capital LLC Fulgent Genetics, Inc. Call Options Transaction History

Walleye Capital LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$19.6 - $25.06 $276,360 - $353,346	-14,100 Reduced 63.8%	8,000 $173,000
Q2 2024 Aug 14, 2024	BUY	$19.09 - $22.57 $290,168 - $343,064	15,200 Added 220.29%	22,100 $433,000
Q1 2024 May 15, 2024	BUY	$21.55 - $29.29 $105,595 - $143,521	4,900 Added 245.0%	6,900 $149,000
Q4 2023 Feb 14, 2024	BUY	$23.64 - $30.27 $47,280 - $60,540	2,000 New	2,000 $57,000
Q1 2023 May 15, 2023	BUY	$29.39 - $36.27 $126,377 - $155,961	4,300 New	4,300 $134,000
Q3 2022 Nov 14, 2022	BUY	$37.92 - $63.74 $3,792 - $6,374	100 New	100 $4,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.